These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29293940)

  • 1. Effect of Concomitant Positive Hepatitis B Surface Antigen on the Risk of Liver Metastasis: A Retrospective Clinical Study of 4033 Consecutive Cases of Newly Diagnosed Colorectal Cancer.
    Huo T; Cao J; Tian Y; Shi X; Wu L; Zhang M; Wong LL; Zhao L
    Clin Infect Dis; 2018 Jun; 66(12):1948-1952. PubMed ID: 29293940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active Chronic Hepatitis B increases the risk of Colorectal Liver Metastasis - A retrospective cross-sectional study.
    Yang Y; Song L; Cao J; Liu J; Wang D; Wong LL; Zhao L
    J Cancer; 2021; 12(5):1398-1405. PubMed ID: 33531985
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B.
    Wang J; Ding W; Liu J; Liu Y; Yan X; Xia J; Wu W; Jia B; Chen Y; Gao D; Hong S; Wang X; Wang L; Tong X; Yin S; Zhang Z; Li J; Huang R; Wu C
    JAMA Netw Open; 2022 Jun; 5(6):e2216485. PubMed ID: 35696167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity].
    Gao Y; Zou G; Ye J; Pan G; Rao J; Li F; Wei Y; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):254-7. PubMed ID: 26133815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infection.
    Huang C; Li Q; Xu W; Wang Q; Hu Q; Zhang X; Huang Y; Chen L
    Discov Med; 2020; 29(157):119-128. PubMed ID: 33002408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B surface antigen in late hepatitis B infection.
    Zeng DW; Zhu YY; Huang Q; Zhang JM; Wu YL; Dong J; Jiang JJ; Liu YR
    J Med Virol; 2015 Mar; 87(3):380-7. PubMed ID: 25604455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepatitis B surface antigen correlates with fibrosis and necroinflammation: A multicentre perspective in China.
    Zhang P; Du HB; Tong GD; Li XK; Sun XH; Chi XL; Xing YF; Zhou ZH; Li Q; Chen B; Wang H; Wang L; Jin H; Mao DW; Wang XB; Wu QK; Li FP; Hu XY; Lu BJ; Yang ZY; Zhang MX; Shi WB; He Q; Li Y; Jiang KP; Xue JD; Li XD; Jiang JM; Lu W; Tian GJ; Hu ZB; Guo JC; Li CZ; Deng X; Luo XL; Li FY; Zhang XW; Zheng YJ; Zhao G; Wang LC; Wu JH; Guo H; Mi YQ; Gong ZJ; Wang CB; Jiang F; Guo P; Yang XZ; Shi WQ; Yang HZ; Zhou Y; Sun NN; Jiao YT; Gao YQ; Zhou DQ; Ye YA
    J Viral Hepat; 2018 Sep; 25(9):1017-1025. PubMed ID: 29624802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Non-alcoholic Fatty Liver Disease on the Risk of Synchronous Liver Metastasis: Analysis of 451 Consecutive Patients of Newly Diagnosed Colorectal Cancer.
    Lv Y; Zhang HJ
    Front Oncol; 2020; 10():251. PubMed ID: 32181157
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
    Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
    Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection.
    Hsu CS; Liu WL; Chao YC; Lin HH; Tseng TC; Wang CC; Chen DS; Kao JH
    Hepatol Int; 2015 Apr; 9(2):231-42. PubMed ID: 25788201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
    J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
    Sanai FM; Farah T; Albeladi K; Batwa F; Dahlan Y; Babatin MA; Al-Ashgar H; AlMana H; Alsaad KS; AlSwat K; Aljumah A; AlTraif IH; Kailani BE; Bzeizi KI
    BMC Gastroenterol; 2017 Aug; 17(1):101. PubMed ID: 28841822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?
    Chakrabarty G; Bruce M; Horner M; Wang B; Agarwal K; Carey I
    J Viral Hepat; 2018 Jan; 25(1):80-87. PubMed ID: 28710798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.